VLST is backed by an experienced group of capital investment firms. The Company was initially launched by the Accelerator Corporation, an investment vehicle supporting the formation and development of next-generation biotechnology companies.  In June 2006, VLST closed a $55 million Series B financing. Current investors in VLST include: